Financials
Financial year 2025
PHARMALINE from Courcelles, company number BE0428751579, closed financial year 2025 with a result of € 48,353 after tax. For that financial year PHARMALINE recorded a gross margin of € 190,260 and equity of € 6,388. Compared with financial year 2024, the result moved from € 59,973 to € 48,353. The company is profitable. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 24, 2026.
€ 6,388
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 48,353
▼ 19% vs 2024
Profit after tax over the fiscal year.
€ 89,766
▼ 68% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 48,353 paid out
100 % of the profit went to the shareholders, mostly to COFRANIS (100 % of the shares). That is where the money ends up.
People and assets in 2025
2
▼ 0.1 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 123,412
▲ 6% vs 2024
€ 61,700 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 1,006
▼ 47% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 118,995
▼ 20% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 17,914
▼ 19% vs 2024
Wages, holiday pay and social contributions still to pay. No outstanding taxes.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 192,637 | € 166,650 | € 198,540 | € 190,260 | ▼ 4% |
| Profit after taxes | € 79,756 | € 42,546 | € 59,973 | € 48,353 | ▼ 19% |
| Equity | € 8,248 | € 8,248 | € 6,388 | € 6,388 | |
| Total debts | € 451,728 | € 494,171 | € 517,937 | € 333,166 | ▼ 36% |
| Cash | € 220,253 | € 263,183 | € 276,292 | € 89,766 | ▼ 68% |
| Retained profit | € 1,859 | € 1,859 | € 0 | € 0 | |
| Dividend | € 88,304 | € 42,546 | € 61,832 | € 48,353 | ▼ 22% |
| Balance sheet total | € 459,975 | € 502,418 | € 524,325 | € 339,554 | ▼ 35% |
| Employees (FTE) | 1.9 | 2.1 | 2.1 | 2 | ▼ 0.1 |
Key figures of PHARMALINE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMALINE?
What happened at PHARMALINE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 48,353 (▼ 19% vs 2024). Source: NBB ↗
- New establishment in Courcelles. KBO
- New establishment in Courcelles. KBO
- Start of the company according to the CBE. KBO
In short
From € 79,756 profit in 2022 to € 48,353 profit in 2025.
Paid € 79,626 in corporate taxes since 2022.
Best year ever: 2022, with € 79,756 profit.
On average € 95,100 of value added per employee in 2025.
Establishments
Establishment units
Physical locations of this company
Rue de Chapelle(TR) 5
6183 Courcelles
Rue de Chapelle(TR) 7
6183 Courcelles
Active since 1 January 2017
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0428.751.579
- VAT number
- BE 0428.751.579
- Registered office
- Rue de Chapelle(TR) 5, 6183 Courcelles
- Names & denominations
- PHARMALINE · PHARMAKO
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 25 March 1986
- Peppol
- Active · Active since 14 Dec 2025
- Activities · NACE
Apothekers
Detailhandel in farmaceutische producten